ACRS vs IBM · rev $3.6M vs P/E 25, rev $17.16B
Aclaris Therapeutics Inc (ACRS) versus International Business Machines (IBM) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
International Business Machines (IBM) is a information technology services company listed on US. It is led by Arvind Krishna.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
Latest reported IBM revenue for 2026-06-30 was $17.16B. Net income was $2.17B. Revenue was up 7.8% from 2026-03-31 to 2026-06-30. IBM currently screens at market cap $267.72B and trailing P/E 25.2.
ACRS currently screens at market cap $615.9M. IBM currently screens at market cap $267.72B and trailing P/E 25.2.
Not investment advice. Open the ACRS and IBM stock pages for the full models.
Not investment advice.